Literature DB >> 26844758

Clinical management of medications in pregnancy and lactation.

Lorene A Temming1, Alison G Cahill2, Laura E Riley3.   

Abstract

Prescription and over-the-counter medication use during pregnancy and lactation is exceedingly common. There are many available resources to gather information and guide patient counseling. These include primary literature, online resources, professional society recommendations, and drug labels. One must consider both disease and drug characteristics when making decisions on medication use during pregnancy and lactation. Providers can then use this information to balance the risks of fetal or neonatal exposure against the potential benefits of maternal treatment and the risks of untreated disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  medications in lactation; medications in pregnancy; psychiatric medications in pregnancy

Mesh:

Substances:

Year:  2016        PMID: 26844758      PMCID: PMC4884467          DOI: 10.1016/j.ajog.2016.01.187

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  23 in total

1.  Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008.

Authors:  Allen A Mitchell; Suzanne M Gilboa; Martha M Werler; Katherine E Kelley; Carol Louik; Sonia Hernández-Díaz
Journal:  Am J Obstet Gynecol       Date:  2011-04-22       Impact factor: 8.661

2.  First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.

Authors:  Carol Louik; Angela E Lin; Martha M Werler; Sonia Hernández-Díaz; Allen A Mitchell
Journal:  N Engl J Med       Date:  2007-06-28       Impact factor: 91.245

Review 3.  Recent changes in pregnancy and lactation labeling: retirement of risk categories.

Authors:  Leda L Ramoz; Nima M Patel-Shori
Journal:  Pharmacotherapy       Date:  2014-01-04       Impact factor: 4.705

Review 4.  ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation.

Authors: 
Journal:  Obstet Gynecol       Date:  2008-04       Impact factor: 7.661

Review 5.  Antidepressant use during pregnancy: the benefit-risk ratio.

Authors:  Gideon Koren; Hedvig Nordeng
Journal:  Am J Obstet Gynecol       Date:  2012-02-21       Impact factor: 8.661

6.  Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.

Authors:  N A Kulin; A Pastuszak; S R Sage; B Schick-Boschetto; G Spivey; M Feldkamp; K Ormond; D Matsui; A K Stein-Schechman; L Cook; J Brochu; M Rieder; G Koren
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

7.  Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

Authors:  Christina D Chambers; Sonia Hernandez-Diaz; Linda J Van Marter; Martha M Werler; Carol Louik; Kenneth Lyons Jones; Allen A Mitchell
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

8.  Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention--convened meeting.

Authors:  Cheryl S Broussard; Meghan T Frey; Sonia Hernandez-Diaz; Michael F Greene; Christina D Chambers; Leyla Sahin; Beth A Collins Sharp; Margaret A Honein
Journal:  Am J Obstet Gynecol       Date:  2014-05-29       Impact factor: 8.661

9.  The transfer of drugs and therapeutics into human breast milk: an update on selected topics.

Authors:  Hari Cheryl Sachs
Journal:  Pediatrics       Date:  2013-08-26       Impact factor: 7.124

10.  An overview of upcoming changes in pregnancy and lactation labeling information.

Authors:  Juan F Mosley; Lillian L Smith; Megan D Dezan
Journal:  Pharm Pract (Granada)       Date:  2015-06-15
View more
  2 in total

1.  A population-based study of concurrent prescriptions of opioid analgesic and selective serotonin reuptake inhibitor medications during pregnancy and risk for adverse birth outcomes.

Authors:  Ayesha C Sujan; Martin E Rickert; Patrick D Quinn; Christina Ludema; Kelsey K Wiggs; Henrik Larsson; Paul Lichtenstein; Catarina Almqvist; Anna Sara Öberg; Brian M D'Onofrio
Journal:  Paediatr Perinat Epidemiol       Date:  2020-12-22       Impact factor: 3.980

2.  Improving Safe and Effective Use of Drugs in Pregnancy and Lactation: Workshop Summary.

Authors:  Laura E Riley; Alison G Cahill; Richard Beigi; Renate Savich; George Saade
Journal:  Am J Perinatol       Date:  2017-01-31       Impact factor: 1.862

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.